FDA and CDC expand approval of updated Moderna and Pfizer-BioNTech COVID-19 booster vaccines for children Ages 5-17
Author
Blaire Bryant
Upcoming Events
Related News
Key Takeaways
On October 12, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 vaccines for children ages 5-17. Under the amended EUA, the Moderna vaccine is authorized for children ages 6 through 17 years of age, and the Pfizer vaccine is authorized for children five to 11 years of age.
Following FDA authorization, the Centers for Disease Control and Prevention (CDC), updated their COVID-19 vaccination recommendations to include the boosters for this younger age group.
Updated COVID-19 boosters add Omicron BA.4 and BA.5 variants to the current vaccine composition, helping to restore protection that has waned since previous vaccination and targeting recent Omicron strains that are more transmissible and immune compromising.
The approval of the updated COVID-19 boosters is a critical next step in the nation’s pandemic recovery efforts. County governments have been on the front lines of our nation’s vaccination efforts and will continue to work to coordinate distribution and administration of vaccines, which provide increased protection against severe COVID-19 disease and mortality.
ADDITIONAL RESOURCES
Resource
The County Role in Vaccines
Related News
Engaging people with ‘lived experience’ helps build substance use disorder programming
Philadelphia’s Keli McLoyd noted to NACo's Health Steering Committee that increased harm reduction initiatives have led to fewer drug overdose deaths.
CMS announces grant awards to improve the continuity of care for justice-involved individuals
On September 27, the Centers for Medicare & Medicaid Services announced $106.5 million in state planning grants aimed at improving healthcare continuity for individuals transitioning from incarceration.
SAMHSA releases new 2024 data on rates of mental illness and substance use disorder in the U.S.
On July 28, the U.S. Department of Health and Human Services’ (HHS) Substance Abuse and Mental Health Services Administration (SAMHSA) released the findings of its annual National Survey on Drug Use and Health (NSDUH), which provides data on rates of substance use and mental illness at the national, state and local level.